LON:RTW RTW Biotech Opportunities (RTW) Share Price, News & Analysis GBX 1.40 0.00 (0.00%) As of 11:46 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About RTW Biotech Opportunities Stock (LON:RTW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RTW alerts:Sign Up Key Stats Today's Range 1.40▼ 1.4150-Day Range 1.15▼ 1.4152-Week Range 1.08▼ 1.58Volume652,132 shsAverage Volume299,570 shsMarket Capitalization£470.28 millionP/E Ratio3.34Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies. Read More Receive RTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTW Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RTW Stock News HeadlinesThe healthcare sector is unloved – this trust is a prime exampleJuly 17, 2025 | finance.yahoo.comRTWFF RTW Biotech Opportunities Ltd - Seeking AlphaJuly 1, 2025 | seekingalpha.comINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.August 29 at 2:00 AM | Traders Agency (Ad)RTW Biotech hails Corxel obesity drug progress in US, China trialsJune 24, 2025 | lse.co.ukThis trust buys shares that can double in a day or be wiped out. The risk could be worth itJune 19, 2025 | finance.yahoo.comRTW Biotech investee sees encouraging results in cardiac disease trialMay 20, 2025 | lse.co.ukRTW Biotech Opportunities Ltd schedules June AGMMay 16, 2025 | investing.comRTW Biotech Opportunities notes positive trial data from investeeMay 2, 2025 | lse.co.ukSee More Headlines RTW Stock Analysis - Frequently Asked Questions How have RTW shares performed this year? RTW Biotech Opportunities' stock was trading at GBX 1.39 on January 1st, 2025. Since then, RTW shares have increased by 0.7% and is now trading at GBX 1.40. How do I buy shares of RTW Biotech Opportunities? Shares of RTW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:RTW CIKN/A Webwww.rtwfunds.com Phone646-597-6980FaxN/AEmployees4,971Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.42 Trailing P/E Ratio3.34 Forward P/E RatioN/A P/E GrowthN/ANet Income£14.09 billion Net Margins664.38% Pretax MarginN/A Return on Equity25.18% Return on Assets-0.47% Debt Debt-to-Equity Ratio2.27 Current RatioN/A Quick Ratio0.81 Sales & Book Value Annual Sales£2.12 billion Price / Sales0.22 Cash FlowGBX 4.35 per share Price / Cash Flow0.32 Book ValueGBX 210.25 per share Price / Book0.01Miscellaneous Outstanding Shares33,591,400,000Free FloatN/AMarket Cap£470.28 million OptionableNot Optionable Beta0.60 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (LON:RTW) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access